FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1845759787> ?p ?o ?g. }

• W1845759787 endingPage "515" @default.
• W1845759787 startingPage "506" @default.
• W1845759787 abstract "The classic approach of controlled volunteer studies to study drug metabolism is difficult or impossible to undertake for novel psychoactive substances (NPS), as there is generally very limited information available to allow appropriate dose finding and safety. A viable and powerful alternative is the identification and characterization of phase I and II metabolites of such drugs by examining the concordance of data gathered from analysis of microsomal incubates with that from analysis of specimens collected from individuals with analytically confirmed use of NPS. Liquid chromatography-high resolution mass spectrometry provides the ability to reliably identify such metabolites. We used this technique here to study the metabolism of the ketamine analogue methoxetamine. A large number of metabolites were identified in the in vitro studies including normethoxetamine, O-desmethylmethoxetamine, dihydromethoxetamine, dehydromethoxetamine and several structural isomers of hydroxymethoxetamine and hydroxynormethoxetamine. pH dependent liquid-liquid extraction was used to discriminate phenolic from alcoholic metabolites. Phase II glucuronide conjugates included those of O-desmethylmethoxetamine, O-desmethylnormethoxetamine and O-desmethylhydroxymethoxetamine. The majority of these phase I and II metabolites were confirmed to be present in urine collected from three individuals presenting with acute methoxetamine toxicity. Copyright © 2013 John Wiley & Sons, Ltd." @default.
• W1845759787 created "2016-06-24" @default.
• W1845759787 creator A5003404779 @default.
• W1845759787 creator A5008370160 @default.
• W1845759787 creator A5008773662 @default.
• W1845759787 creator A5019447625 @default.
• W1845759787 creator A5072780912 @default.
• W1845759787 date "2013-11-05" @default.
• W1845759787 modified "2023-10-09" @default.
• W1845759787 title "Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine" @default.
• W1845759787 cites W1827642231 @default.
• W1845759787 cites W1998467888 @default.
• W1845759787 cites W2005357412 @default.
• W1845759787 cites W2013294274 @default.
• W1845759787 cites W2023615425 @default.
• W1845759787 cites W2030152904 @default.
• W1845759787 cites W2031683838 @default.
• W1845759787 cites W2043113964 @default.
• W1845759787 cites W2102794287 @default.
• W1845759787 cites W2108777919 @default.
• W1845759787 cites W2130973111 @default.
• W1845759787 cites W3004896432 @default.
• W1845759787 doi "https://doi.org/10.1002/dta.1541" @default.
• W1845759787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24574323" @default.
• W1845759787 hasPublicationYear "2013" @default.
• W1845759787 type Work @default.
• W1845759787 sameAs 1845759787 @default.
• W1845759787 citedByCount "51" @default.
• W1845759787 countsByYear W18457597872013 @default.
• W1845759787 countsByYear W18457597872014 @default.
• W1845759787 countsByYear W18457597872015 @default.
• W1845759787 countsByYear W18457597872016 @default.
• W1845759787 countsByYear W18457597872017 @default.
• W1845759787 countsByYear W18457597872018 @default.
• W1845759787 countsByYear W18457597872019 @default.
• W1845759787 countsByYear W18457597872020 @default.
• W1845759787 countsByYear W18457597872021 @default.
• W1845759787 countsByYear W18457597872022 @default.
• W1845759787 countsByYear W18457597872023 @default.
• W1845759787 crossrefType "journal-article" @default.
• W1845759787 hasAuthorship W1845759787A5003404779 @default.
• W1845759787 hasAuthorship W1845759787A5008370160 @default.
• W1845759787 hasAuthorship W1845759787A5008773662 @default.
• W1845759787 hasAuthorship W1845759787A5019447625 @default.
• W1845759787 hasAuthorship W1845759787A5072780912 @default.
• W1845759787 hasConcept C118552586 @default.
• W1845759787 hasConcept C158342456 @default.
• W1845759787 hasConcept C162356407 @default.
• W1845759787 hasConcept C170493617 @default.
• W1845759787 hasConcept C185592680 @default.
• W1845759787 hasConcept C202751555 @default.
• W1845759787 hasConcept C2776678776 @default.
• W1845759787 hasConcept C2777477808 @default.
• W1845759787 hasConcept C2777846614 @default.
• W1845759787 hasConcept C2778961205 @default.
• W1845759787 hasConcept C2779186261 @default.
• W1845759787 hasConcept C2780026642 @default.
• W1845759787 hasConcept C2780035454 @default.
• W1845759787 hasConcept C2780871563 @default.
• W1845759787 hasConcept C3019607171 @default.
• W1845759787 hasConcept C43617362 @default.
• W1845759787 hasConcept C55493867 @default.
• W1845759787 hasConcept C62231903 @default.
• W1845759787 hasConcept C71924100 @default.
• W1845759787 hasConcept C81426234 @default.
• W1845759787 hasConcept C87644729 @default.
• W1845759787 hasConcept C89311334 @default.
• W1845759787 hasConcept C98274493 @default.
• W1845759787 hasConceptScore W1845759787C118552586 @default.
• W1845759787 hasConceptScore W1845759787C158342456 @default.
• W1845759787 hasConceptScore W1845759787C162356407 @default.
• W1845759787 hasConceptScore W1845759787C170493617 @default.
• W1845759787 hasConceptScore W1845759787C185592680 @default.
• W1845759787 hasConceptScore W1845759787C202751555 @default.
• W1845759787 hasConceptScore W1845759787C2776678776 @default.
• W1845759787 hasConceptScore W1845759787C2777477808 @default.
• W1845759787 hasConceptScore W1845759787C2777846614 @default.
• W1845759787 hasConceptScore W1845759787C2778961205 @default.
• W1845759787 hasConceptScore W1845759787C2779186261 @default.
• W1845759787 hasConceptScore W1845759787C2780026642 @default.
• W1845759787 hasConceptScore W1845759787C2780035454 @default.
• W1845759787 hasConceptScore W1845759787C2780871563 @default.
• W1845759787 hasConceptScore W1845759787C3019607171 @default.
• W1845759787 hasConceptScore W1845759787C43617362 @default.
• W1845759787 hasConceptScore W1845759787C55493867 @default.
• W1845759787 hasConceptScore W1845759787C62231903 @default.
• W1845759787 hasConceptScore W1845759787C71924100 @default.
• W1845759787 hasConceptScore W1845759787C81426234 @default.
• W1845759787 hasConceptScore W1845759787C87644729 @default.
• W1845759787 hasConceptScore W1845759787C89311334 @default.
• W1845759787 hasConceptScore W1845759787C98274493 @default.
• W1845759787 hasFunder F4320334629 @default.
• W1845759787 hasIssue "6" @default.
• W1845759787 hasLocation W18457597871 @default.
• W1845759787 hasLocation W18457597872 @default.
• W1845759787 hasOpenAccess W1845759787 @default.
• W1845759787 hasPrimaryLocation W18457597871 @default.
• W1845759787 hasRelatedWork W1845759787 @default.

• next